- Home
- HLP vs ZTEK Comparison
HLP vs ZTEK Comparison
Compare HLP & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- ZTEK
- Stock Information
- Founded
- HLP 2021
- ZTEK 2008
- Country
- HLP China
- ZTEK Canada
- Employees
- HLP N/A
- ZTEK N/A
- Industry
- HLP Industrial Machinery/Components
- ZTEK Major Chemicals
- Sector
- HLP Industrials
- ZTEK Industrials
- Exchange
- HLP Nasdaq
- ZTEK Nasdaq
- Market Cap
- HLP 102.1M
- ZTEK 89.3M
- IPO Year
- HLP 2023
- ZTEK N/A
- Fundamental
- Price
- HLP $1.70
- ZTEK $0.81
- Analyst Decision
- HLP
- ZTEK
- Analyst Count
- HLP 0
- ZTEK 0
- Target Price
- HLP N/A
- ZTEK N/A
- AVG Volume (30 Days)
- HLP 88.0K
- ZTEK 77.9K
- Earning Date
- HLP 05-15-2026
- ZTEK 11-14-2025
- Dividend Yield
- HLP N/A
- ZTEK N/A
- EPS Growth
- HLP N/A
- ZTEK N/A
- EPS
- HLP 0.02
- ZTEK N/A
- Revenue
- HLP $16,731,357.00
- ZTEK $678,078.00
- Revenue This Year
- HLP N/A
- ZTEK N/A
- Revenue Next Year
- HLP N/A
- ZTEK N/A
- P/E Ratio
- HLP $80.27
- ZTEK N/A
- Revenue Growth
- HLP 19.13
- ZTEK 2519.47
- 52 Week Low
- HLP $0.61
- ZTEK $0.62
- 52 Week High
- HLP $1.82
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- HLP 69.04
- ZTEK 47.96
- Support Level
- HLP $1.50
- ZTEK $0.78
- Resistance Level
- HLP $1.65
- ZTEK $0.85
- Average True Range (ATR)
- HLP 0.10
- ZTEK 0.07
- MACD
- HLP 0.00
- ZTEK -0.00
- Stochastic Oscillator
- HLP 96.12
- ZTEK 31.37
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll-formed steel profile manufacturer in China. It customizes and manufactures cold roll-formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation. Geographically, the company generates the majority of its revenue from the PRC.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.